InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by Lippoldt Darin, Directeur Juridique. Officer active across 1 companies, notably Neurocrine Biosciences INC. Aggregated, 7 filings have been logged. Total volume traded: €111k. The latest transaction was disclosed on 8 December 2025 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
US$162,5554,376 shares@ US$37.14710.0011% mcap79.3% of flow
Common Stock
SEC:0001504783-25-000006·
€162,5554,376 shares@ €37.14710.0011% mcap37.3% of flow
Common Stock
SEC:0001504783-25-000006:0·
€25,677300 shares@ €85.58930.0002% mcap5.9% of flow
Common Stock
SEC:0001209191-22-020615:0·
€42,539605 shares@ €70.31280.0003% mcap20.7% of flow
Common Stock
SEC:0001209191-22-008213·
€42,539605 shares@ €70.31280.0003% mcap9.8% of flow
Common Stock
SEC:0001209191-22-008213:0·
0120 shares0
Common Stock
SEC:0001209191-21-069625·
0120 shares0
Common Stock
SEC:0001209191-21-069625:0·
7 of 7 declarations
About Lippoldt Darin
Darin Lippoldt is the Chief Legal Officer of Neurocrine Biosciences Inc. He is responsible for managing the company's legal affairs, including regulatory compliance and intellectual property issues. His role is crucial in protecting Neurocrine's legal interests and supporting its business objectives.
